Mycobacterium Abscessus Infection
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Oregon TherapeuticsEpetraborole
Beyond AirNitric Oxide
Clinical Trials (2)
Total enrollment: 93 patients across 2 trials
Epetraborole in Patients With Mycobacterium Abscessus Lung Disease
Start: Mar 2026Est. completion: Dec 202784 patients
Phase 2Not Yet Recruiting
Inhaled Nitric Oxide for Patients With MABSC
Start: Jul 2017Est. completion: Apr 20199 patients
Phase 2Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.